Advertisement

Topics

PAION: Russischer Lizenzpartner startet Phase-III-Studie

10:20 EDT 7 Aug 2017 | FinanzNachrichten

Das Aachener BioTech-Unternehmen PAION AG (ISIN: DE000A0B65S3) hat am Nachmittag darüber berichtet, dass der russische Lizenzpartner R-Pharm mit der Patientenrekrutierung für eine Phase-III-Studie ...

Original Article: PAION: Russischer Lizenzpartner startet Phase-III-Studie

NEXT ARTICLE

More From BioPortfolio on "PAION: Russischer Lizenzpartner startet Phase-III-Studie"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...